GOSSAMER BIO, INC.: operating cash flow
Operating cash flow for GOSSAMER BIO, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All GOSSAMER BIO, INC. financial histories
What this measure means
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
Exact concept: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -171,266,000 | USD | 2026-03-17 | 10-K · 0001728117-26-000017 |
| 2024-01-01 | 2024-12-31 | -3,468,000 | USD | 2026-03-17 | 10-K · 0001728117-26-000017 |
| 2023-01-01 | 2023-12-31 | -159,158,000 | USD | 2026-03-17 | 10-K · 0001728117-26-000017 |
| 2022-01-01 | 2022-12-31 | -187,032,000 | USD | 2025-03-13 | 10-K · 0001728117-25-000021 |
| 2021-01-01 | 2021-12-31 | -188,890,000 | USD | 2024-03-05 | 10-K · 0001728117-24-000019 |
| 2020-01-01 | 2020-12-31 | -176,360,000 | USD | 2023-03-17 | 10-K · 0001728117-23-000010 |
| 2019-01-01 | 2019-12-31 | -144,834,000 | USD | 2022-03-03 | 10-K · 0001728117-22-000019 |
| 2018-01-01 | 2018-12-31 | -51,044,000 | USD | 2021-02-26 | 10-K · 0001728117-21-000019 |
| 2017-01-01 | 2017-12-31 | -5,745,000 | USD | 2020-03-24 | 10-K · 0001564590-20-012323 |
Related financial histories
- GOSSAMER BIO, INC.: total assets
- GOSSAMER BIO, INC.: total liabilities
- GOSSAMER BIO, INC.: stockholders equity
- GOSSAMER BIO, INC.: cash and cash equivalents
- GOSSAMER BIO, INC.: net income or loss
- GOSSAMER BIO, INC.: capital expenditure payments
- GOSSAMER BIO, INC.: contract revenue excluding tax
- GOSSAMER BIO, INC.: financing cash flow
- GOSSAMER BIO, INC.: investing cash flow
- GOSSAMER BIO, INC.: retained earnings or deficit
- GOSSAMER BIO, INC.: basic weighted-average shares
- GOSSAMER BIO, INC.: diluted weighted-average shares
- GOSSAMER BIO, INC.: basic earnings per share
- GOSSAMER BIO, INC.: diluted earnings per share
- GOSSAMER BIO, INC.: income tax expense or benefit
- GOSSAMER BIO, INC.: net property, plant and equipment
- GOSSAMER BIO, INC.: share-based compensation expense
- GOSSAMER BIO, INC.: operating income or loss
- GOSSAMER BIO, INC.: current assets
- GOSSAMER BIO, INC.: interest expense
- GOSSAMER BIO, INC.: current liabilities
- GOSSAMER BIO, INC.: current accounts payable
- GOSSAMER BIO, INC.: net current accounts receivable
- GOSSAMER BIO, INC.: operating expenses
Inspect the source
- Entity
- GOSSAMER BIO, INC. / CIK 0001728117
- Captured
- 2026-09-21T17:25:19.528Z
- SEC response SHA-256
f7b698dc7f7952a1ecde7dad30fb4cda447556105984dc7709c97900b64c7f69
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001728117.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))